Skip to main content

BI Asset Management Fondsmaeglerselskab A/S

Position in NBIX — Neurocrine Biosciences Inc

CIK 1778131 KOBENHAVN, G7

Position in NBIX

as of Jun 30, 2026 · filed Aug 10, 2026
Position Value
$5,597,381
+$5,004,947 QoQ
Shares Held
33,211
+638.5% QoQ
Ownership
0.033%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#201
of 768 holders
Holding Since
Sep 2020
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

BI Asset Management Fondsmaeglerselskab A/S holds $42,638,294 across 9 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (13.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 NBIX
Neurocrine Biosciences Inc
This page
33,211 $5,597,381

All Filings in NBIX

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,597,381 33,211
2026-03-31 $592,434 4,497
2025-12-31 $1,106,699 7,803
2025-09-30 $1,130,760 8,055
2025-06-30 $617,263 4,911
2025-03-31 $546,032 4,937
2024-12-31 $1,681,953 12,322
2024-09-30 $1,986,968 17,245
2024-06-30 $196,455 1,427
2024-03-31 $680,911 4,937
2023-12-31 $487,775 3,702
2023-09-30 $158,962 1,413
2023-06-30 $133,245 1,413
2023-03-31 $1,100,261 10,870
2022-12-31 $527,208 4,414
2020-09-30 $15,193 158